KLRD1 and metabolic dysfunction-associated steatotic liver disease: HLA‐G supports immune tolerance,46 and HLA‐E interacts with the natural killer inhibitory receptor KLRD1/NKG2A, which was up‐regulated in all MASLD cases47 (Figure S10C).